Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-02-29 | Karyopharm Therapeutics Inc. | Rangwala Reshma
(EVP & Chief Medical Officer) |
S | Common | D | 21636 | $1.17 - $1.20 | $25,492 |
| 2024-02-29 | Karyopharm Therapeutics Inc. | Poulton Stuart
(EVP, Chief Development Officer) |
S | Common | D | 22466 | $1.17 - $1.20 | $26,469 |
| 2024-02-29 | Karyopharm Therapeutics Inc. | Mason Michael
(EVP, CFO & Treasurer) |
S | Common | D | 33849 | $1.17 - $1.20 | $39,787 |
| 2024-02-29 | Karyopharm Therapeutics Inc. | Mano Michael
(SVP, General Counsel&Secretary) |
S | Common | D | 20549 | $1.17 - $1.20 | $24,149 |
| 2024-02-29 | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan
(EVP & Chief Commercial Officer) |
S | Common | D | 26949 | $1.17 - $1.20 | $31,682 |
| 2024-02-29 | Karyopharm Therapeutics Inc. | Paulson Richard A.
(President and CEO) |
S | Common | D | 99844 | $1.17 - $1.20 | $117,397 |
| 2024-02-28 | Karyopharm Therapeutics Inc. | Rangwala Reshma
(EVP & Chief Medical Officer) |
A | Common Stock | A | 198959 | $0.00 - $0.00 | $0 |
| 2024-02-28 | Karyopharm Therapeutics Inc. | Poulton Stuart
(EVP, Chief Development Officer) |
A | Common Stock | A | 188205 | $0.00 - $0.00 | $0 |
| 2024-02-27 | Karyopharm Therapeutics Inc. | Mason Michael
(EVP, CFO & Treasurer) |
S | Common Stock | D | 2545 | $1.32 - $1.32 | $3,369 |
| 2024-02-28 | Karyopharm Therapeutics Inc. | Mason Michael
(EVP, CFO & Treasurer) |
A | Common Stock | A | 188205 | $0.00 - $0.00 | $0 |
| 2024-02-28 | Karyopharm Therapeutics Inc. | Mano Michael
(SVP, General Counsel&Secretary) |
A | Common Stock | A | 147000 | $0.00 - $0.00 | $0 |
| 2024-02-28 | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan
(EVP & Chief Commercial Officer) |
A | Common Stock | A | 198959 | $0.00 - $0.00 | $0 |
| 2024-02-28 | Karyopharm Therapeutics Inc. | Paulson Richard A.
(President and CEO) |
A | Common Stock | A | 442800 | $0.00 - $0.00 | $0 |
| 2024-02-15 | Karyopharm Therapeutics Inc. | Poulton Stuart
(EVP, Chief Development Officer) |
S | Common Stock | D | 5847 | $1.33 - $1.40 | $7,782 |
| 2024-02-06 | Karyopharm Therapeutics Inc. | Mason Michael
(EVP, CFO & Treasurer) |
S | Common Stock | D | 4205 | $1.59 - $1.59 | $6,671 |
| 2024-01-24 | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan
(EVP & Chief Commercial Officer) |
A | Common Stock | A | 14167 | $0.00 - $0.00 | $0 |
| 2024-01-24 | Karyopharm Therapeutics Inc. | Rangwala Reshma
(EVP & Chief Medical Officer) |
A | Common Stock | A | 14167 | $0.00 - $0.00 | $0 |
| 2024-01-24 | Karyopharm Therapeutics Inc. | Poulton Stuart
(EVP, Chief Development Officer) |
A | Common Stock | A | 13333 | $0.00 - $0.00 | $0 |
| 2024-01-24 | Karyopharm Therapeutics Inc. | Mano Michael
(SVP, General Counsel&Secretary) |
A | Common Stock | A | 9167 | $0.00 - $0.00 | $0 |
| 2024-01-24 | Karyopharm Therapeutics Inc. | Mason Michael
(EVP, CFO & Treasurer) |
A | Common Stock | A | 13333 | $0.00 - $0.00 | $0 |
| 2024-01-24 | Karyopharm Therapeutics Inc. | Paulson Richard A.
(President and CEO) |
A | Common Stock | A | 42000 | $0.00 - $0.00 | $0 |
| 2024-01-04 | Karyopharm Therapeutics Inc. | Paulson Richard A.
(President and CEO) |
S | Common Stock | D | 4114 | $0.82 - $0.82 | $3,373 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |